And The World’s Largest Drug Maker Will Be…
November 2nd, 2011 // 12:17 pm @ jmpickett
Pretty soon, it will no longer be Pfizer. Instead, Sanofi is expected to become the No. 1 drugmaker next year and stay on top until at least 2016, by which time Pfizer will slide to third place, behind Novartis, according to the latest calculation by EvaluatePharma. The fall from grace is, of course, largely attributed to the patent expiration for the Lipitor cholesterol pill and the subsequent loss of revenue.
Meanwhile, Sanofi has climbed the ranks thanks to acquistions, notably the recent purchase of Genzyme, troubled as the biotech may be with ongoing production problems. The deal added meds that should boost sales to help offset the loss of revenues from the Plavix bloodthinner, which loses US patent protection next year, and ongoing generic erosion of Lovenox and Taxotere, the consulting firm writes (you can read the rest of the analysis here).
World’s Top 15 Drugmakers by 2016
Market Rank
Sanofi
Novartis
Pfizer
Glaxo
Roche
Merck
AstraZeneca
Teva
Abbott
Bayer
Takeda
Bristol-Myers
Novo
Eli Lilly
Source: Pharmalot
